University of San Francisco

USF Health Launches $28 Million Hyperbaric Oxygen Therapy Trial for TBI in Veterans

5 months ago

• USF Health has initiated a $28 million clinical trial to evaluate hyperbaric oxygen therapy (HBOT) for traumatic brain injury (TBI) in Florida veterans and service members. • The five-year, double-blind, placebo-controlled study will monitor physiological signs to assess HBOT's effectiveness, with placebo participants offered HBOT treatment post-study. • Championed by Florida House Speaker Paul Renner, the trial aims to provide definitive scientific evidence on HBOT's efficacy for TBI and potential benefits for the broader community. • The study, led by Dr. Harry van Loveren, involves a multidisciplinary team and leverages USF Health's extensive TBI research expertise to maximize research investment return.